List of Tables
Table 1. Global Molecular Infectious Disease Testing Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Molecular Infectious Disease Testing Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Molecular Infectious Disease Testing Market Competitive Situation by Manufacturers in 2024
Table 4. Global Molecular Infectious Disease Testing Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Molecular Infectious Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Molecular Infectious Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Molecular Infectious Disease Testing Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Molecular Infectious Disease Testing, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Molecular Infectious Disease Testing, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Molecular Infectious Disease Testing, Product Type & Application
Table 12. Global Key Manufacturers of Molecular Infectious Disease Testing, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Infectious Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Infectious Disease Testing as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Molecular Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 18. Global Molecular Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 19. Global Molecular Infectious Disease Testing Sales by Region (2026-2031) & (K Units)
Table 20. Global Molecular Infectious Disease Testing Sales Market Share by Region (2026-2031)
Table 21. Global Molecular Infectious Disease Testing Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Table 23. Global Molecular Infectious Disease Testing Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Molecular Infectious Disease Testing Revenue Market Share by Region (2026-2031)
Table 25. North America Molecular Infectious Disease Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 27. North America Molecular Infectious Disease Testing Sales by Country (2026-2031) & (K Units)
Table 28. North America Molecular Infectious Disease Testing Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Molecular Infectious Disease Testing Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Molecular Infectious Disease Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 32. Europe Molecular Infectious Disease Testing Sales by Country (2026-2031) & (K Units)
Table 33. Europe Molecular Infectious Disease Testing Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Molecular Infectious Disease Testing Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Molecular Infectious Disease Testing Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Molecular Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Molecular Infectious Disease Testing Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Molecular Infectious Disease Testing Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Molecular Infectious Disease Testing Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Molecular Infectious Disease Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Molecular Infectious Disease Testing Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Molecular Infectious Disease Testing Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Infectious Disease Testing Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Molecular Infectious Disease Testing Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Molecular Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Molecular Infectious Disease Testing Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Molecular Infectious Disease Testing Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Molecular Infectious Disease Testing Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Molecular Infectious Disease Testing Sales (K Units) by Type (2020-2025)
Table 51. Global Molecular Infectious Disease Testing Sales (K Units) by Type (2026-2031)
Table 52. Global Molecular Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 53. Global Molecular Infectious Disease Testing Sales Market Share by Type (2026-2031)
Table 54. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2020-2025)
Table 57. Global Molecular Infectious Disease Testing Revenue Market Share by Type (2026-2031)
Table 58. Global Molecular Infectious Disease Testing Price (US$/Unit) by Type (2020-2025)
Table 59. Global Molecular Infectious Disease Testing Price (US$/Unit) by Type (2026-2031)
Table 60. Global Molecular Infectious Disease Testing Sales (K Units) by Application (2020-2025)
Table 61. Global Molecular Infectious Disease Testing Sales (K Units) by Application (2026-2031)
Table 62. Global Molecular Infectious Disease Testing Sales Market Share by Application (2020-2025)
Table 63. Global Molecular Infectious Disease Testing Sales Market Share by Application (2026-2031)
Table 64. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Molecular Infectious Disease Testing Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Molecular Infectious Disease Testing Revenue Market Share by Application (2020-2025)
Table 67. Global Molecular Infectious Disease Testing Revenue Market Share by Application (2026-2031)
Table 68. Global Molecular Infectious Disease Testing Price (US$/Unit) by Application (2020-2025)
Table 69. Global Molecular Infectious Disease Testing Price (US$/Unit) by Application (2026-2031)
Table 70. Danaher Company Information
Table 71. Danaher Description and Business Overview
Table 72. Danaher Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Danaher Molecular Infectious Disease Testing Product
Table 74. Danaher Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Molecular Infectious Disease Testing Product
Table 79. Roche Recent Developments/Updates
Table 80. bioMérieux Company Information
Table 81. bioMérieux Description and Business Overview
Table 82. bioMérieux Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. bioMérieux Molecular Infectious Disease Testing Product
Table 84. bioMérieux Recent Developments/Updates
Table 85. Hologic Company Information
Table 86. Hologic Description and Business Overview
Table 87. Hologic Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Hologic Molecular Infectious Disease Testing Product
Table 89. Hologic Recent Developments/Updates
Table 90. Abbott Company Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Abbott Molecular Infectious Disease Testing Product
Table 94. Abbott Recent Developments/Updates
Table 95. Thermo Fisher Scientific Company Information
Table 96. Thermo Fisher Scientific Description and Business Overview
Table 97. Thermo Fisher Scientific Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Thermo Fisher Scientific Molecular Infectious Disease Testing Product
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. QIAGEN Company Information
Table 101. QIAGEN Description and Business Overview
Table 102. QIAGEN Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. QIAGEN Molecular Infectious Disease Testing Product
Table 104. QIAGEN Recent Developments/Updates
Table 105. Revvity Company Information
Table 106. Revvity Description and Business Overview
Table 107. Revvity Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Revvity Molecular Infectious Disease Testing Product
Table 109. Revvity Recent Developments/Updates
Table 110. Grifols Company Information
Table 111. Grifols Description and Business Overview
Table 112. Grifols Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Grifols Molecular Infectious Disease Testing Product
Table 114. Grifols Recent Developments/Updates
Table 115. Seegene Company Information
Table 116. Seegene Description and Business Overview
Table 117. Seegene Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Seegene Molecular Infectious Disease Testing Product
Table 119. Seegene Recent Developments/Updates
Table 120. DiaSorin Company Information
Table 121. DiaSorin Description and Business Overview
Table 122. DiaSorin Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. DiaSorin Molecular Infectious Disease Testing Product
Table 124. DiaSorin Recent Developments/Updates
Table 125. Siemens Healthineers Company Information
Table 126. Siemens Healthineers Description and Business Overview
Table 127. Siemens Healthineers Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Siemens Healthineers Molecular Infectious Disease Testing Product
Table 129. Siemens Healthineers Recent Developments/Updates
Table 130. BD Company Information
Table 131. BD Description and Business Overview
Table 132. BD Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. BD Molecular Infectious Disease Testing Product
Table 134. BD Recent Developments/Updates
Table 135. QuidelOrtho Company Information
Table 136. QuidelOrtho Description and Business Overview
Table 137. QuidelOrtho Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. QuidelOrtho Molecular Infectious Disease Testing Product
Table 139. QuidelOrtho Recent Developments/Updates
Table 140. Bruker Company Information
Table 141. Bruker Description and Business Overview
Table 142. Bruker Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Bruker Molecular Infectious Disease Testing Product
Table 144. Bruker Recent Developments/Updates
Table 145. Genetic Signatures Company Information
Table 146. Genetic Signatures Description and Business Overview
Table 147. Genetic Signatures Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Genetic Signatures Molecular Infectious Disease Testing Product
Table 149. Genetic Signatures Recent Developments/Updates
Table 150. Co-Diagnostics Company Information
Table 151. Co-Diagnostics Description and Business Overview
Table 152. Co-Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Co-Diagnostics Molecular Infectious Disease Testing Product
Table 154. Co-Diagnostics Recent Developments/Updates
Table 155. Vela Diagnostics Company Information
Table 156. Vela Diagnostics Description and Business Overview
Table 157. Vela Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Vela Diagnostics Molecular Infectious Disease Testing Product
Table 159. Vela Diagnostics Recent Developments/Updates
Table 160. Molbio Diagnostics Company Information
Table 161. Molbio Diagnostics Description and Business Overview
Table 162. Molbio Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Molbio Diagnostics Molecular Infectious Disease Testing Product
Table 164. Molbio Diagnostics Recent Developments/Updates
Table 165. Savyon Diagnostics Company Information
Table 166. Savyon Diagnostics Description and Business Overview
Table 167. Savyon Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Savyon Diagnostics Molecular Infectious Disease Testing Product
Table 169. Savyon Diagnostics Recent Developments/Updates
Table 170. Uniogen Oy Company Information
Table 171. Uniogen Oy Description and Business Overview
Table 172. Uniogen Oy Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Uniogen Oy Molecular Infectious Disease Testing Product
Table 174. Uniogen Oy Recent Developments/Updates
Table 175. geneOmbio Technologies Company Information
Table 176. geneOmbio Technologies Description and Business Overview
Table 177. geneOmbio Technologies Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. geneOmbio Technologies Molecular Infectious Disease Testing Product
Table 179. geneOmbio Technologies Recent Developments/Updates
Table 180. Advanced Molecular Diagnostics Company Information
Table 181. Advanced Molecular Diagnostics Description and Business Overview
Table 182. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Advanced Molecular Diagnostics Molecular Infectious Disease Testing Product
Table 184. Advanced Molecular Diagnostics Recent Developments/Updates
Table 185. altona Diagnostics Company Information
Table 186. altona Diagnostics Description and Business Overview
Table 187. altona Diagnostics Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. altona Diagnostics Molecular Infectious Disease Testing Product
Table 189. altona Diagnostics Recent Developments/Updates
Table 190. GeneFirst Company Information
Table 191. GeneFirst Description and Business Overview
Table 192. GeneFirst Molecular Infectious Disease Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 193. GeneFirst Molecular Infectious Disease Testing Product
Table 194. GeneFirst Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Molecular Infectious Disease Testing Distributors List
Table 198. Molecular Infectious Disease Testing Customers List
Table 199. Molecular Infectious Disease Testing Market Trends
Table 200. Molecular Infectious Disease Testing Market Drivers
Table 201. Molecular Infectious Disease Testing Market Challenges
Table 202. Molecular Infectious Disease Testing Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Molecular Infectious Disease Testing
Figure 2. Global Molecular Infectious Disease Testing Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Infectious Disease Testing Market Share by Type: 2024 & 2031
Figure 4. Multiplex Testing Product Picture
Figure 5. Singleplex Testing Product Picture
Figure 6. Global Molecular Infectious Disease Testing Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Molecular Infectious Disease Testing Market Share by Application: 2024 & 2031
Figure 8. Diagnostic Laboratories
Figure 9. Hospitals and Clinics
Figure 10. Others
Figure 11. Global Molecular Infectious Disease Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Molecular Infectious Disease Testing Market Size (2020-2031) & (US$ Million)
Figure 13. Global Molecular Infectious Disease Testing Sales (2020-2031) & (K Units)
Figure 14. Global Molecular Infectious Disease Testing Average Price (US$/Unit) & (2020-2031)
Figure 15. Molecular Infectious Disease Testing Report Years Considered
Figure 16. Molecular Infectious Disease Testing Sales Share by Manufacturers in 2024
Figure 17. Global Molecular Infectious Disease Testing Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Molecular Infectious Disease Testing Players: Market Share by Revenue in Molecular Infectious Disease Testing in 2024
Figure 19. Molecular Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Molecular Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Molecular Infectious Disease Testing Sales Market Share by Country (2020-2031)
Figure 22. North America Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2031)
Figure 23. United States Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Molecular Infectious Disease Testing Sales Market Share by Country (2020-2031)
Figure 26. Europe Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2031)
Figure 27. Germany Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Molecular Infectious Disease Testing Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Molecular Infectious Disease Testing Revenue Market Share by Region (2020-2031)
Figure 34. China Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Molecular Infectious Disease Testing Sales Market Share by Country (2020-2031)
Figure 42. Latin America Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Molecular Infectious Disease Testing Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Molecular Infectious Disease Testing Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Molecular Infectious Disease Testing Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Molecular Infectious Disease Testing by Type (2020-2031)
Figure 53. Global Revenue Market Share of Molecular Infectious Disease Testing by Type (2020-2031)
Figure 54. Global Molecular Infectious Disease Testing Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Molecular Infectious Disease Testing by Application (2020-2031)
Figure 56. Global Revenue Market Share of Molecular Infectious Disease Testing by Application (2020-2031)
Figure 57. Global Molecular Infectious Disease Testing Price (US$/Unit) by Application (2020-2031)
Figure 58. Molecular Infectious Disease Testing Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
